Ameritas Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.86M | Sell |
4,593
-63
| -1% | -$42.9K | 0.08% | 269 |
|
|
2026
Q1 | $3.6M | Buy |
4,656
+20
| +0.4% | +$15.3K | 0.11% | 167 |
|
|
2025
Q4 | $3.58M | Buy |
4,636
+230
| +5% | +$156K | 0.11% | 158 |
|
|
2025
Q3 | $2.48M | Sell |
4,406
-51
| -1% | -$28.8K | 0.08% | 266 |
|
|
2025
Q2 | $2.34M | Sell |
4,457
-64
| -1% | -$35.7K | 0.07% | 278 |
|
|
2025
Q1 | $2.87M | Buy |
4,521
+57
| +1% | +$39.2K | 0.1% | 192 |
|
|
2024
Q4 | $3.18M | Buy |
4,464
+127
| +3% | +$107K | 0.1% | 175 |
|
|
2024
Q3 | $4.56M | Buy |
4,337
+74
| +2% | +$82.4K | 0.15% | 108 |
|
|
2024
Q2 | $4.48M | Sell |
4,263
-9
| -0.2% | -$8.72K | 0.15% | 101 |
|
|
2024
Q1 | $4.11M | Sell |
4,272
-25
| -0.6% | -$23.8K | 0.14% | 125 |
|
|
2023
Q4 | $3.77M | Buy |
4,297
+111
| +3% | +$91.4K | 0.14% | 124 |
|
|
2023
Q3 | $3.44M | Buy |
4,186
+564
| +16% | +$443K | 0.14% | 125 |
|
|
2023
Q2 | $2.6M | Buy |
3,622
+4
| +0.1% | +$3.08K | 0.1% | 206 |
|
|
2023
Q1 | $2.97M | Buy |
3,618
+49
| +1% | +$37K | 0.12% | 167 |
|
|
2022
Q4 | $2.61M | Sell |
3,569
-127
| -3% | -$93.7K | 0.1% | 203 |
|
|
2022
Q3 | $2.55M | Sell |
3,696
-42
| -1% | -$26.4K | 0.11% | 164 |
|
|
2022
Q2 | $2.21M | Buy |
3,738
+39
| +1% | +$25.4K | 0.1% | 213 |
|
|
2022
Q1 | $2.58M | Buy |
3,699
+3
| +0.1% | +$1.9K | 0.09% | 231 |
|
|
2021
Q4 | $2.33M | Buy |
3,696
+33
| +0.9% | +$20.3K | 0.08% | 280 |
|
|
2021
Q3 | $2.22M | Hold |
3,663
| – | – | 0.08% | 269 |
|
|
2021
Q2 | $2.05M | Hold |
3,663
| – | – | 0.07% | 308 |
|
|
2021
Q1 | $1.73M | Sell |
3,663
-41
| -1% | -$20K | 0.07% | 350 |
|
|
2020
Q4 | $1.79M | Buy |
3,704
+99
| +3% | +$53.4K | 0.08% | 298 |
|
|
2020
Q3 | $2.02M | Sell |
3,605
-3
| -0.1% | -$1.82K | 0.09% | 227 |
|
|
2020
Q2 | $2.25M | Buy |
3,608
+154
| +4% | +$87.4K | 0.11% | 180 |
|
|
2020
Q1 | $1.69M | Sell |
3,454
-57
| -2% | -$23.5K | 0.1% | 216 |
|
|
2019
Q4 | $1.32M | Buy |
3,511
+131
| +4% | +$44.1K | 0.06% | 406 |
|
|
2019
Q3 | $938K | Hold |
3,380
| – | – | 0.04% | 531 |
|
|
2019
Q2 | $1.06M | Sell |
3,380
-4
| -0.1% | -$1.33K | 0.05% | 489 |
|
|
2019
Q1 | $1.39M | Buy |
3,384
+68
| +2% | +$28K | 0.06% | 369 |
|
|
2018
Q4 | $1.24M | Buy |
3,316
+55
| +2% | +$20.1K | 0.07% | 354 |
|
|
2018
Q3 | $1.32M | Sell |
3,261
-96
| -3% | -$36.5K | 0.06% | 413 |
|
|
2018
Q2 | $1.16M | Sell |
3,357
-123
| -4% | -$38.5K | 0.06% | 463 |
|
|
2018
Q1 | $1.2M | Sell |
3,480
-89
| -2% | -$31K | 0.06% | 453 |
|
|
2017
Q4 | $1.34M | Sell |
3,569
-53
| -1% | -$21.5K | 0.06% | 418 |
|
|
2017
Q3 | $1.8M | Hold |
3,622
| – | – | 0.09% | 276 |
|
|
2017
Q2 | $1.78M | Hold |
3,622
| – | – | 0.09% | 269 |
|
|
2017
Q1 | $1.4M | Sell |
3,622
-39
| -1% | -$14.5K | 0.07% | 369 |
|
|
2016
Q4 | $1.34M | Hold |
3,661
| – | – | 0.07% | 385 |
|
|
2016
Q3 | $1.47M | Buy |
3,661
+298
| +9% | +$120K | 0.08% | 313 |
|
|
2016
Q2 | $1.17M | Buy |
3,363
+162
| +5% | +$62.4K | 0.08% | 257 |
|
|
2016
Q1 | $1.15M | Buy |
3,201
+31
| +1% | +$12.8K | 0.08% | 254 |
|
|
2015
Q4 | $1.72M | Buy |
3,170
+32
| +1% | +$17.3K | 0.12% | 190 |
|
|
2015
Q3 | $1.46M | Buy |
3,138
+56
| +2% | +$30.1K | 0.1% | 214 |
|
|
2015
Q2 | $1.57M | Buy |
3,082
+61
| +2% | +$29.8K | 0.1% | 212 |
|
|
2015
Q1 | $1.36M | Sell |
3,021
-24
| -0.8% | -$10.2K | 0.09% | 234 |
|
|
2014
Q4 | $1.25M | Buy |
3,045
+19
| +0.6% | +$7.47K | 0.09% | 235 |
|
|
2014
Q3 | $1.09M | Sell |
3,026
-288
| -9% | -$96.5K | 0.08% | 267 |
|
|
2014
Q2 | $936K | Sell |
3,314
-148
| -4% | -$43.9K | 0.07% | 311 |
|
|
2014
Q1 | $1.04M | Sell |
3,462
-76
| -2% | -$23.4K | 0.08% | 277 |
|
|
2013
Q4 | $974K | Buy |
3,538
+1,887
| +114% | +$543K | 0.08% | 295 |
|
|
2013
Q3 | $517K | Buy |
+1,651
| New | +$434K | 0.05% | 495 |
|
Other funds holding REGN
Ameritas Investment Partners's REGN Position: Q2 2026 in Review
Ameritas Investment Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q2 2026, selling an estimated $42.9K and leaving 4,593 shares worth $2.86M. The position accounts for 0.08% of the portfolio, ranked #269.
Ameritas Investment Partners first reported a position in REGN in Q3 2013 and has held it in 52 quarters since. The position peaked at $4.56M in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Ameritas Investment Partners held 4,593 shares of Regeneron Pharmaceuticals worth $2.86M as of Q2 2026.
- Ameritas Investment Partners sold 63 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $42.9K.
- Regeneron Pharmaceuticals made up 0.08% of Ameritas Investment Partners's portfolio in Q2 2026, its #269 holding.
- Ameritas Investment Partners first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- Ameritas Investment Partners's Regeneron Pharmaceuticals position peaked at $4.56M in Q3 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.